Pacific Edge’s American dream

Pacific Edge’s American dream
The US Affordable Care Act can be tricky to navigate. (Image: Getty)
Paul McBeth
Pacific Edge has long wanted to crack the United States market, which it has seen for a long time as validating the hundreds of millions spent in developing its Cxbladder non-invasive cancer detection tool. More than 20 years since listing, after it was spun out of University of Otago research, the company has raised $297.23 million selling shares and convertible preference shares and as people exercised options to fund accumulated losses of $216.8m and counting. That’s not going to change any time soon after the company crashed...

More Markets

The pros and cons of Sky’s big deal
Markets

Eden Bradfield: The pros and cons of Sky’s big deal

You'd best hope streaming and advertising revenue make up for the $1 purchase.

Infratil and Ebos help drive NZ stocks higher
Markets Market Close

Infratil and Ebos help drive NZ stocks higher

Infrastructure investor helped the sharemarket end the week on a positive note.

Tom Raynel 25 Jul 2025
Bathurst fails to strike-out Talley's claims
Markets

Bathurst fails to strike-out Talley's claims

Talley's is alleging Companies Act breaches by its coal JV partner.

Pattrick Smellie 25 Jul 2025
New CFO for KMD Brands
Markets

New CFO for KMD Brands

Carla Webb-Sear has been appointed group chief financial officer for KMD Brands.She will join the group executive team on Aug 4 and report to Brent Scrimshaw, group chief executive and managing director.She joins KMD Brands from Qantas, where she was chief financial and strategy...

Staff reporters 25 Jul 2025